Prion radicals, a marriage
between the big and the small
疯牛病毒蛋白自由基-大与小的结合
Chi Ming Yang
(中国科学院化学所 北京 100080)
Abstract When all the experimental evidence from prion research are reconciled, my
interpretation of the available data argues that persuasive evidence suggests that
putative forms of persistent sequence-specific prion radicals in transmissible spongiform
encephalopathies (TSEs) can be responsible for the infectious agent. A mechanism
corresponding to the self-replication of scrapie protein mediated by prion radicals is
proposed. My analysis argues that prions replicate via a prion radical-mediated chain
process and the generation of the prion radicals is associated with reactive oxidative
species. All of the unusual nature of prion diseases in mammals can be explained by
invoking the prion protein radicals.
Key words Persistent sequence-specific prion radicals,
Transmissible spongiform encephalopathy (TSE), Scrapie self-replication, Protein
oxidation, Creutzfeldt-Jakob Disease (CJD)
关键词 疯牛病毒 序列专一长寿命蛋白自由基 传染性
蛋白氧化 分子自我复制
Prion radicals, a marriage
between the big and the small
Chi Ming Yang
(San Diego Institute for Life Science & Health and Dept of Chem & Biochem,
UCSD,
P. O. Box 12035, La Jolla, CA 92039, USA and Institute of Chemistry, Chinese Academy of
Sciences, Beijing 100080)
Introduction
Prion diseases are fatal neurodegenerative disorders in mammalian species. This group of
diseases includes scrapie in sheep, Bovine Spongiform Encephalopathy (BSE) in cattle, and
Creutzfeldt-Jakob Disease (CJD) in humans [1]. Since the pioneering work by
Prusiner and co-workers, who characterized the scrapie protein at a molecular level and
built a bridge between research on scrapie and modern molecular biology of prions [2,3,4],
past many years have seen tremendous advancement in prion research [1-6]. To
date many important features of molecular genetics associated with prion diseases have
been elegantly elucidated, including that the prion protein gene Prnp is a requirement for
prion disease, elimination of this gene will abolish disease infection [4], a
piece of strongly supporting evidence for the protein-only hypothesis. However, mainly
because of the prion strain diversity [7] and lack of the ultimate prove of
protein-only theory [5,6], it is suspected that something must have been
missing [5,6,8]. Facing a scenario that bovine spongiform encephalopathy (BSE)
may have passed to human [9], we urgently need a few new concepts to resolve
the prion enigma in order to facilitate drug development.
On one hand, there is no doubt for the importance
of prion protein folding problem in prion diseases [10]. On the other hand,
facing the perplexing prion disease, an immediate question, which is central to mammalian
species including humans, can be asked: In addition to those macromolecules involved in
the diseases, is there any role for the smallest but the most vital species, oxygen, for
mammals on this planet in the pathogenic process? The benign cellular prion protein (PrPC)
which is crucial to the disease is expressed on the cell-surface of neurons and massive
experiments have shown that the transmissible agent of scrapie (PrPSc) is found
most abundantly in brain homogenates of diseased individuals [11]. It is known
that brain tissue has a remarkably high respiration rate, for instance, the human brain
constitutes only about 2% of the adult body mass, but about 20% of its resting oxygen
consumption of the whole body, independent of the state of mental activity. Unfortunately,
throughout the prion research history, oxygen has very rarely been mentioned [12,13].
Prion infectivity is also called “slow virus” infection, during that from 5 up to 20
year incubation period, is there any involvement of oxygen in the pathogenesis? Moreover,
it was reported from scrapie research that scrapie infectivity would not be lost even when
the scrapie agent was allowed to stay in air for up to two years [14]. Now the
scrapie protein has been excellently identified and sequenced [15], and several
informative reviews on prions have recently sparked renewed interest in understanding the
intriguing feature of the disease [1,5,8,16]. For chemists, it may be skeptical
whether a protein molecule containing more than 10 His, more than 10 Tyr, and multiple Trp
residues in its sequence, is so stable towards oxygen.
Rational to the prion replicating mechanism
Oxidative damage to proteins
Oxidative damage to proteins has been implicated in
the pathogenesis of many neurodegenerative disorders such as Alzheimer’s disease [17,18].
The oxidative damage is usually believed to be mediated via rapid attack on proteins by
reactive oxidative species such as hydroxyl radicals, which are generated by either Fenton
type reactions or other metal ion-mediated reaction [19]. All the mammals use
haemoglobin to transport oxygen from the lung to the tissue [20], which
provides one possible pathway to the generation of hydroxyl radicals. In addition, recent
biochemical and biophysical study revealed the tight and co-operative binding of the
benign protein with copper (Ⅱ) ion [21,22], implying its good ability to
generate reactive oxygen species, via a number of chemical processes. Oxidative damage to
proteins produces protein radicals as primary products, which can be further reactive
towards other protein molecules.
Tyrosyl radicals
Tyrosine radical has been believed to play important
roles in biological systems such as in ribonucleotide reductase [23].
Considering the bond dissociation energies [24] of all the covalent bonds
formed between a hydrogen atom and other atoms, oxygen, nitrogen, and carbon atoms of
different hybridisation in a protein molecule such as prion protein without any free
cysteinyl thiol groups, we can summarise their relative thermodynamic bond dissociation
energy scales in the following table (Table 1)
As we know that the lower the bond dissociation
energy scale is for a covalent bond, the easier the formation of the corresponding radical
upon hydrogen atom abstraction by hydroxyl radicals; and the easier the formation of a
radical, the more stable the radical [24]. Consequently, the phenoxyl radical
on tyrosine (or called tyrosyl radical) is the most stable primary protein radical which
can be generated from this prion protein molecule. Irvin and co-workers recently reported
that radical transfer from one protein molecule to another protein molecule is mediated by
protein oxidative damage [25]. Besides, recent studies also showed that Trp
residue can form peroxyl radical which can then react rapidly with a wide range of
proteins to give long-lived ( persistent) secondary radicals on the Tyr residues of the
targeted proteins [26].
Table 1. Bond dissociation energies (BDE)
of covalent bond H-X
Bond (H-X) |
BDE ( kcal·mole-1,
298 ºK ) |
H—OH |
119 |
H—OC(O)CH3 |
112 |
H—NH2 |
103 |
H—Phe (benzene) |
103 |
H—OCH3 |
102 |
H—CH2CH3 |
98 |
H—CH2OH |
93 |
H—CH2Phe |
85 |
H—O-Phe (~Tyrosyl) |
85 |
|
Examine the sequence of the human normal prion
protein PrPC, in addition to many His and Trp residues at the N-terminus, more
than ten Tyr residues at the C-terminal domain can be found in this molecule. The Tyr
residues at the C-terminal domain of human prion protein sequence are illustrated here:
Y128 --Y145 -- Y149Y150
-- Y157-- Y162Y163--Y169 - Y218 - Y225Y226
It can be expected that the protein molecule is
very prone to oxidative attack at Tyr residues by reactive oxidative species such as the
notorious hydroxyl radicals.
Initiation of prion radicals
Upon hydrogen atom abstraction from the protein
molecule by a hydroxyl radical, presumably at the tyrosine residues, a protein free
radical can be formed. According to the nature of radical species, it can subsequently
damage other protein molecules, accompanied by cross-linking and production of secondary
(new) protein free radicals. Recall this prion radical is on a >208-residue
glycoprotein molecule with a rigid tertiary structure at the C-terminal core, it is not
inconceivable that it may be very difficult to quench it, and its damaging property can be
sequence-specific. Based on the unusual properties of the prion scrapie infectivity, which
copurify with the scrapie protein PrPSc [1], its unusual stability including
resistance to UV irradiation which often kill virus containing nucleic acids, its unusual
resistance to harsh chemical treatment [2], I hereby postulate that putative
forms of sequence-specific prion radicals are responsible for the infectivity in the prion
particles. In other words, the infectious, transmissible agent is the free radical form of
scrapie prion protein. The scrapie radical is physically unable to be separated from the
neutral form of prion scrapie and it is sequence-specific in both binding and damaging
other molecules. The difference between the PrPSc and PrPSc radical
is apparently one electron or one hydrogen atom. Shown here are the formation of simple
forms of prion radicals without detailed discussion of their structures [27].
PrP-H +·OH→PrP·+ H2O |
or |
PrP + [O]→[PrP] +·
+ [O] -· |
Prion radical-mediated scrapie replication
A free radical chain propagation is characterized by
three sequential steps, i.e., radical initiation, radical propagation and radical
termination [28]. Since there is no evidence for the involvement of any
classical virion or viroids in the development of prion diseases after many year
competitive research using powerful molecular biology technique, facing mounting evidence
supporting that only a protein is involved, I therefore point out that prion disease
replicating mechanism displays strikingly high similarity to a free radical-induced
polymerization of a molecule through an autocatalytic chain propagation [28,29],
with the help of partial sequence specificity in protein binding.
Here, using “N-C” to represent the cellular
form of prion protein PrPC, where N represents the N-terminal domain, which
contains poly octarepeats, and C is C-terminal domain. Using“N-C i” to
represent protein molecule i, with i = 1 and 2 for species 1 and species 2, respectively.
Using “N-D” to represent the scrapie form of the prion protein. Then prion disease
propagation can be described to proceed via the following free radical-chain propagation
mechanism:
Protein radical initiation
The initial formation of prion protein radical,
presumably on Tyr residues at C-terminus, via hydrogen atom abstraction by hydroxyl
radicals, in step (b), occurs in the beginning of sporadic prion disease. The feasibility
for the formation of this protein radical is governed by both the PrP protein sequence
encoded by the Prnp gene and oxidative stress in the host.
|
? →OH |
(a) |
|
N-C1+ ·OH→N-C1·+
H2O |
△Gb < 0 |
(b) |
Disease propagation
The protein radical then undergoes an irreversible
radical-induced structural transformation at C-terminal domain to form scrapie protein,
which is thermodynamically more stable, step (c), whereby intramolecular Tyr-Tyr and/or
Tyr-His cross-linking may or may not be involved,
|
N-C1·→N-D1· [PrPSc] |
△Gc < 0 |
(c) |
The resulting scrapie protein “N-D1· ”
is still a radical, therefore it can react with a second benign protein molecule in step
(d), and carries the chain.
|
N-D1· + N-C2→N-D1
[PrPSc] + N-C2· |
△Gd = ? |
(d) |
|
N-C2·→N-D2·
[PrPSc] |
△Ge < 0 |
(e) |
Step (d) is an inter-molecular sequence-specific
radical-transfer process, which is dependent of sequence compatibility between the two
protein molecules,“N-D1”and “N-C2”, and it is also the
rate-limiting step in the whole pathogenic process as soon as the first scrapie prion
radical is generated. Therefore this stage is also the infectious stage if protein
molecules N-C1 and N-C2 are of different sequences from two
different species, with the protein radical, “N-D1·”, being
the infectious agent. The resulting scrapie protein, “N-D1”,becomes
non-infectious scrapie after step (d), since it has transferred the radical to the second
molecule,“N-C2” and the newly formed radical, “N-D2·”,
becomes the infectious particle.
Besides being able to transfer the radical to a
second molecule, the radical form of scrapie prion,“N-D1· ”, may
also undergo intermolecular radical addition-reaction to form radical-mediated
cross-linking adducts with a second protein molecule, (see Figure 1) presumably on the
aromatic rings of Tyr and/or His residues at the C-terminal domain in another prion
protein molecule. The subsequently formed dimerized product is again in a radical form in
scrapie deposits, shown in step (c)’,
|
N-D1· + N-C1→(N-D1)(
N-C1)· [PrPSc] |
△Gc’ < 0 |
(c)’ |
Since the resulting scrapie protein adduct from
step (c)’is again a radical, and it can react with still another benign protein
molecule, step (d)’,
| |
(N-D1)( N-C1)·+ N-C2
→
(N-D1)( N-C1) [PrPSc] + N-C2· |
△Gd’=? |
(d)’ |
which is followed by scrapie formation of the second
species in step (e). Thus, in the scrapie plaque, only those protein deposits which are in
the radical form, are infectious in initiating further damaging processes to other benign
protein molecules; while most deposits which are in non-radical forms, are not infectious.
Theoretically, the Gibbs free energy change △G associated with each step in the chain
mechanism is < 0, except step (d) or (d)’, which is the rate-determining step, with
its △G value being dependent of sequence compatibility between the two protein molecules
of different sequences from species 1 and species 2, indicating the species barrier and
possibility of crossing the barrier. Since there are several pathways to generating
scrapie prions, as shown in the above reactions, and the resulting prion radicals can
further damage each other depending on the time of incubation and the location of the
radicals within the protein molecules, recall that multiple Tyr and His residues are
available in the molecule. All may explain the PrPSc strain diversity.
Therefore, the diseased-form protein PrPSc
is the structurally transformed protein, here represented by,“N-D” and polymer,“(N-D1)(
N-C1)” , formed via a free radical-chain process, with the free radicals,
“N-D·”, and polymer radicals,“(N-D)(N-C)· ”, which can be of
several protein structural conformations, being the infectious particles occluded in the
solid deposits. The radical species retains partial sequence-specificity in attacking
other molecules. We can also understand from here, as long as a scrapie protein radical,
“N-D1·” , is generated in the initial stage, the radical
carries a very long chain, through sequential free radical transfer reactions to an
unlimited number of other labile benign prion protein molecules.
Moreover, it is this radical species, “N-D·”,
or polymer radicals,“(N-D)(N-C)·”, not only responsible for the persistently
transmissible infectivity, but also being unable to be separated from the neutral form of
scrapie,“ N-D” or polymer,“(N-D)(N-C)”, by virtue of the fact they have the
closely identical molecular weight (±1 of molecular mass unit) as well as the same shape.
Termination
Theoretically, there is a termination step at the end
of this free radical-chain propagation, which can be described as follows:
|
2 N-D·→N-D-D-N |
△G f >>>0 |
(f) |
For very small radicals such as methyl radical CH3 ·at
a high concentration in solution phase, the rate of this coupling reaction is as fast as
diffusion-controlled, with a bimolecular reaction constant of k ~1010 s -1
M -1. Very unfortunately, given the low concentration of the prion radicals,
its solid state limiting its diffusion ability, and its highly steric hindrance with
sequence specific properties of a 208-residues scrapie protein, (the radical is not really
free) these three factors render the chance for two prion radicals come close to be within
a distance of one to two Aº (10-10 meter), in order to be able to form a
covalent bond, is almost zero, leading to a scenario
that radical-chain propagation going on until all
the benign prion protein is consumed and structurally converted. The remaining radicals
will still stay active, as it is shown in Table 1 that tyrosyl radical is one of the most
stable radicals in biological fluids, no good hydrogen donor is available to quench it.
This is demonstrated by its unusual resistance to long-time harsh chemical treatment. The
radical nature of prion can also account for its inactivity towards the immune systems of
mammals, since the infectious part of the agent is not a particular form of a protein but
very tiny in size for it is an unpaired electron.
This interpretation using prion radicals explains
species barrier, strain diversity, mutation effect of the diseases and the possibility of
crossing species-barrier [1], because different species have both different PrP
sequence including polymorphism and different glycoform of the cellular proteins, which
affect the binding before a prion radical damages the second molecule. Protein radicals
can also be powerful enough to damage other proteins regardless of poor binding between
the two protein molecules of different species, thereby leading to the possibility of
crossing the species barrier. The persistent and partially damaged prion radicals render
itself both protease-resistant in nature and infectious pathogen-like properties.
The above suggested mechanism not only explains the
prion disease fully at a molecular level, but also demonstrates that the prion protein is
both necessary and sufficient (for it is infectious) to the disease for mammals which
require oxygen. Meanwhile, the radical-mediated mechanism indicates that the
susceptibility to scrapie is a function of PrPC level in the host.
Additionally, the radical mechanism is consistent with the unimolecular mechanistic model
as well as the unknown protein X, proposed by Prusiner, based on their extensive molecular
genetics study [30]. Moreover, the sequence-specific prion radical of highly
damaging nature allow it to be capable of function like a “virino” species, leading to
the widely observed strains diversity in the prion disease.
The poly octarepeats and the hydrophobic
core
Prion protein (PrP) gene Prnp is found in all the
mammals so far examined, but its normal physiological function is still unclear. The
benign protein PrPC is attached to brain cell surface membranes by its
glycosylphosphatidylinositol anchor, and both the PrPC and PrPSc
were found to be encoded within a single exon of the chromosomal gene as proteins of 254
amino acids [31]. Both the five copies of the poly octapeptide repeats,
(PQGGGGWGQ)(PHGGGWGQ)4, at N-terminus and two hydrophobic segments, (A113GAAAAGAVVGGLGG
Y) and (L234FSSPPVILLISFLIFLIVG) [human numbering],at C-terminal domain are
highly conserved among most mammal species such as human, cow, mouse and hamster [32].
Studies revealed that the N-terminal poly
octarepeats in PrPSc is not required for either transmission or propagation of
infectivity [30], implying that the infectious radical is located at the
C-terminal domain, see Figure 2. It is reported from molecular genetic study that mutated
goats having only three octapeptide repeats are non-pathogenic after challenge with
scrapie [33]. In contrast, normal goats with five copies of octarepeats are
very susceptible to scrapie. While familial (genetic) human CJD patients have from 5 up to
8 extra octarepeats as [PHGGGWGQ] in PrP, compared with five octarepeats at the N-terminus
encoded in human prion protein gene for normal humans [34]. Nevertheless,
transgenic mice ablating 3.5 of the five copies of octarepeats in PrP gene was still shown
to be pathogenic towards PrPSc inoculation [4]. All these simply
indicates that polyoctarepeats at the N-terminus of benign PrP may play a role in the
aetiology of the diseases, or may be evolved to fight back against oxidative damage and
the disease. Further investigation is required to clearify the role of the octarepeats in
PrP protein.
Although it is unknown why the two hydrophobic
segments, (A113GAAAAGAVVGGLGG Y) and (L234FSSPPVILLISFLIFLIVG), in
PrP is so conserved in mammals, it can be speculated from radical-reaction mechanistic
point of view that this hydrophobic cores may unfortunately provide a unique hydrophobic
environment through aggregation in facilitating free radical-mediated cross-linking as
soon as protein radicals are formed in the surrounding.
 |
Figure 2. Prion protein
components |
Protein folding, the big and the small
It is required to be emphasised that protein folding
undoubtedly play an important role in the pathogenesis, in particular in the generation of
the protein radicals and its sequence specificity which determines both species barrier
and possibility of crossing the barrier in the disease. Currently, while the three
dimensional structure of the benign prion protein PrPC has been revealed by NMR
spectroscopy [35], but the non-crystalline, nonhomogeneous scrapie prion
protein PrPSc obstructs its structure from being solved at a high-resolution
level either by NMR or X-ray crystallography [30], which significantly blocks
the effort towards a clear mechanistic elucidation through protein folding investigation.
By invoking the sequence specific prion radical
which is generated from interaction of prion protein with reactive oxidative species,
however, many of the controversial issues associated with the prion enigma can be
resolved. Given biodiversity in nature evolution whereby proteins are employed to play a
myriad role in biological processes, it is entirely conceivable for a chemically mutated
protein through posttranslational processes involving reactive oxidative species, to
protein radicals which are long-lived, transmissible, and sequence-specific damaging
species.
Conclusion
Understanding the molecular mechanism has been the
major focus of intensive research on prion diseases. After many year of investigation on
prions, many lines of evidence mostly from molecular genetic study are strongly supporting
the protein-only hypothesis. It is required to reconcile with the protein-only hypothesis
together with a possibility that if it is likely for a modified protein behave as a new
type of “virino” which modulates the structural transformation between PrPC
and scrapie PrPSc. My analysis argue persuasively, based on a wealth of
knowledge and a body of evidence from prion research, that the feature of prion diseases
can be very well described by a radical chain-propagation mechanism, exhibiting partial
sequence specificity in transforming the benign prion protein to the scarpie protein. The
relative ease in generating these persistent, damaging and highly sequence-specific
protein radical can be used to interpret all the three forms of prion diseases, sporadic,
transmissible, and familial pattern, which are manifested by the three pathways to acquire
the damaging radicals, in the pathogenesis of prion diseases.
Research on protein radicals is still in its
infancy [25,26], sequence specific protein radical is a new concept and it has
never been reported before. However, sequence specific organic free radicals have been
implicated in the function mechanism of antibiotics anti-cancer agents such as
Calicheamicin and Bleomycin, which are among the naturally available chemical nucleases
cleaving nucleic acids via a free radical mechanism [36].
The major arguments for prion protein radicals are
summarised in the following:
1. Brain cells consume very high amount of oxygen, implying that
reactive oxidative species are available;
2. Elimination of the PrP gene makes experimental mice totally resistant to scrapie
infection, but cerebellar cells lacking PrPC are more sensitive to oxidative
stress and undergo cell death more readily than wild-type cells [13],
indicating that oxidative damage to PrP is able to play an important role;
3. The PrP protein molecule is very prone to attack by reactive oxidative species;
4. Protein tyrosyl radicals can be very stable and persistent in the solid aggregate and
transmissible;
5. Prion radicals will not be able to activate the immune systems in mammals since the
infectivity is in a radical form without a defined shape;
6. A protein radical can be very damaging sequence-specifically to labile molecules of
antioxidant features such as PrP;
7. Prion radicals are unable to be separated from neutral scrapie prions [1,4,6,8];
8. Prion radical-mediated chain reaction can be autocatalytic [1,4,6,8];
9. A protein radical can be quenched by antioxidant phenol and stabilized by electron-rich
molecules [1,4,6,8].
While the detailed mechanism for the generation of
these types of protein radicals and their structures remain to be determined with the help
of free radical chemistry and protein folding study, nevertheless, it is clear this
one-electron difference between prion scrapie protein and its free radical form has
generated much debate for many decades. Future studies based on this hypothesis may allow
us to determine the most effective approach to stop prion diseases, and drug design may be
directed towards a combination of antioxidants and sequence-specific protein radical
scavengers.
Acknowledgement
The author gratefully acknowledges the support of K.
C. Wong Education foundation, Hong Kong. The author would also specially thank Dr. Stanley
B. Prusiner in UCSF and his colleagues in UCSD for quickly became interested in the idea
of protein oxidation and prion disease during the period of this menuscript preparation in
early April 1999.
REFERENCES
[1] Prusiner S B, Proc. Natl. Acad. Sci. U.S.A., 1998,
95:13363
[2] Prusiner S B, Science, 1982, 216: 1364.
[3] Prusiner S B, Scott M R, DeArmond S J and Cohen F E, Cell, 1998, 93:337
[4] Weissmann C, FEBS Lett., 1996, 389: 3
[5] Aguzzi A and Weissmann C, Nature, 1997, 389:795
[6] Caughey B and Chesebro B, Trends Cell Biol., 1997, 7:56
[7] Farquhar C F, Somerville R A and Bruce M E, Nature, 1998, 391:345
[8] Chesebro B, Science, 1998, 279:42
[9] Hill A F et al., Nature, 1997, 389:448; Raymond G J et al., Nature, 1997, 388:285
[10] Harrison P M, Bamborough P, Daggett V, Prusiner S B and Cohen F E, Curr. Opin.
Struct. Biol., 1997, 7:53; Jackson G S et al., Science, 1999, 283:1935
[11] Baldwin M A, Cohen F E and Prusiner S B, J. Biol. Chem., 1995, 270:19197
[12] Brown D R, Schmidt B and Kretzschmar H A, Nature, 1997, 380:345
[13] Brown D R, Schaeffer W J, Schmidt B and Kretzschmar H A, Experimental Neurology 1997,
146:104
[14] Pattison I H, Vet. Rec., 1988,123:661
[15] Stahl N et al., Biochemistry, 1993, 32:1991
[16] Edenhofer F, Weiss S, Winnacker E-L and Famulok M, Angew. Chem. Int. Ed. Engl., 1997,
36:1674
[17] Markesbery W R, Free Radical Biol. Med., 1997, 23:134
[18] Hensley K N et al., J. Neurochem., 1995, 65:2146
[19] Stadtman E R, Annu. Rev. Biochem., 1993, 62:797
[20] Wittenberg J B and Wittenberg B A, Annu. Rev. Biophys. Biophys. Chem., 1990, 19:217
[21] Viles J H, et al., Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2042
[22] Stockel J, Safar J, Wallace A C, Cohen F E and Prusiner S B, Biochemistry, 1998,
37:7185; Brown D R, et al., Nature, 1997, 390:684
[23] Stubbe J, Proc. Natl. Acad. Sci. U.S.A., 1998, 95:2723
[24] Lowry T H & Richardson K S, Mechanism and Theory in Organic Chemistry (Harpe
& Row, ed. 3, 1985), pp. 161-5.
[25] Irvin J A, Ostdal H and Davis M J, Archives Biochem & Biophysics, 1999, 362:94
[26] Ostdal H, Andersen H J and Davis M J, Archives Biochem & Biophysics, 1999,
362:105
[27] Although scrapie prions may contain covalent cross-linkages between Tyr and Tyr or
between Tyr and His residues in the molecular deposits, these diaryl ether linkages
(Figure 1) are undetectable by Edman sequencing because of a concentrated trifluoroacetic
acid treatment in the Edman degradation procedure which could cleave the diaryl ether
cross-linkage through acid catalysed hydrolysis. (See Voet D and Voet J G, Biochemistry,
John Wiley & Son, Inc., ed. 2, 1995, pp. 108-110.)
[28] Walling C, Free Radicals in Solution (Wiley, New York, 1957).
[29] Huyser E S, Free Radical Chain Reactions (Wiley, New York, 1970).
[30] Cohen F E and Prusiner S B, Annu. Rev. Biochem., 1998, 67:793
[31] Caughey B, Br. Med. Bull. 1993, 49:860
[32] Marcotte E M and Eisenberg D, Biochemistry, 1999, 38:667
[33] Goldmann W, Chong A, Foster J, Hope J and Hunter N, J. General Virology, 1998,
79:3173
[34] Goldfarb L G et al., Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10926
[35] Riek R, Hornemann S, Wider G, Glockshuber R and Wuthrich K, FEBS Lett., 1997,
413:282; Glockshuber R et al., TIBS, 1997, 22:241
[36] Nicolaou K C et al, Angew. Chem. Int. Ed. Engl., 1993, 32:1377; Stubbe J, Acc. Chem.
Res., 1996, 29:322
[37] Dedicated to Prof. Jiang Xi-Kui on the occasion of his 75. In particular we thank
Prof. Hu Guo-Fu in Harvard Medical School for proof reading of the manuscript and Dr.
Taulane M. Goodmann for technical assistance in molecular modelling.
Chi Ming Yang, Ph.D., research
associate professor.
email: Chiming_Yang@usa.net or ccyang@gpu.srv.ualberta.ca
Received July 20,1999, revised August 15, 1999.
|